How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009–2013

PURPOSE: To explore the prescription patterns of erythropoiesis-stimulating agents (ESAs) in four large Italian geographic areas, where different health policy interventions to promote biosimilar use in routine care are undertaken. METHODS: A retrospective drug utilization study was conducted during...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingrasciotta, Ylenia, Giorgianni, Francesco, Bolcato, Jenny, Chinellato, Alessandro, Pirolo, Roberta, Tari, Daniele Ugo, Troncone, Chiara, Fontana, Andrea, Ientile, Valentina, Gini, Rosa, Santoro, Domenico, Santarpia, Mariacarmela, Genazzani, Armando, Uomo, Ilaria, Pastorello, Maurizio, Addario, Walter Sebastiano Pollina, Scondotto, Salvatore, Cananzi, Pasquale, Caputi, Achille Patrizio, Trifirò, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561997/
https://www.ncbi.nlm.nih.gov/pubmed/26169209
http://dx.doi.org/10.1007/s40259-015-0132-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561997/
https://www.ncbi.nlm.nih.gov/pubmed/26169209
http://dx.doi.org/10.1007/s40259-015-0132-7

Ejemplares similares